Periodontal disease and bacterial vaginosis as genetic and environmental markers for the risk of spontaneous preterm labor and preterm birth

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 12, 2011, Pages 1476-1485

  Sanu, Olaleye ^a   Lamont, Ronald F ^b,c,d  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d HUTZEL HOSPITAL   (United States)

Author keywords

bacterial vaginosis; genetic polymorphism; Periodontal disease; preterm births; preterm labor

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE; MOUTHWASH; NITROIMIDAZOLE; PLACEBO;

ARTICLE; CREAM; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC MARKER; GENETIC POLYMORPHISM; HEALTH CARE COST; HUMAN; INTRAUTERINE INFECTION; MORBIDITY; NEUROLOGIC DISEASE; PERINATAL MORTALITY; PERIODONTAL DISEASE; PREMATURE LABOR; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; VAGINITIS;

DISEASE SUSCEPTIBILITY; ENVIRONMENT; FEMALE; GENETIC MARKERS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OBSTETRIC LABOR, PREMATURE; PERIODONTAL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PROGNOSIS; RISK FACTORS; VAGINOSIS, BACTERIAL;

EID: 80053176809     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.545930     Document Type: Article

References (170)

1. Lancucki L, editor. NHS Maternity Statistics, England: 1995- 96 to 1997-98. London: Department of Health; 2001.
2. Martin J.A, Hamilton BE, Sutton PD, et al. Births: final data for 2005. Natl Vital Stat Rep 2005;56: 1-103.
3. Goldenberg RL, Hauth JC, Andrews WW. Mechanisms of disease: intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-1507. (Pubitemid 30318275)
4. Lamont RF, Jaggat AN. Emerging drug therapies for preventing spontaneous preterm labor and preterm birth. Expert Opin Investig Drugs 2007;16:337-345. (Pubitemid 46394858)
5. Jayasooriya GS, Lamont RF. The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth. Expert Opin Pharmacother 2009;10:1-10.
6. Howson CP, Merialdi M, Lawn JE, Requejo JH, Say L, editors. March of Dimes White paper on preterm birth: The global and regional toll. White plains, New York: The March of Dimes Foundation; 2009.
7. Petrou S, Abangma G, Johnson S, Wolke D, Marlow N. Costs and health utilities associated with extremely preterm birth: evidence from the EPICure study. Value Health 2009;12: 1124-1134.
8. Behrman RE, Butler AS, editors. Preterm birth: causes, consequences, and prevention. Institute of Medicine of the National Academies. Washington, DC: National Academy Press; 2007.
9. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.
10. Pretorious C, Jagatt A, Lamont RF. The relationship between periodontal disease, bacterial vaginosis, and preterm birth. J Perinat Med 2007;35:93-99. (Pubitemid 46385664)
11. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993;81:941-948. (Pubitemid 23168738)
12. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, Sahasrabudhe A, Dewhirst FE. Bacterial diversity in human subgingival Plaque. J. Bacteriol 2001;183:3770-3783. (Pubitemid 32510445)
13. Michalowicz BS, Hodges JS, DiAngelis AJ, Lupo VR, Novak MJ, Ferguson JE, Buchanan W, Bofill J, Papapanou PN, Mitchell DA, et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 2006;355:1885-1894. (Pubitemid 44664646)
14. Oittinen J, Kurki T, Kekk M, Kuusisto M, Pussinen P, Vilkuna- Rautiainen T, Nieminen A, Asikainen S, Paavonen J. Periodontal disease and bacterial vaginosis increase the risk for adverse pregnancy outcome Infect Dis Obstet Gynecol 2005;13: 213-216. (Pubitemid 44897534)
15. Steel JH, Malato S, Kennea N, Edwards AD, Miles L, Duggan P, Reynolds PR, Feldman RG, Sullivan MH. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labour. Pediatr Res 2005;57:404-411. (Pubitemid 40293609)
16. Bearfield C, Davenport E, Sivapathasundaram V, Allaker R. Possible association between amniotic fluid microorganism infection and microflora in the mouth. BJOG 2002;109:527-533. (Pubitemid 37337993)
17. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1998;31:553-584.
18. Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labour versus indicated delivery. Am J. Obstet. Gynecol. 1995;173:606-612.
19. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135-176. (Pubitemid 27182276)
20. CassellG, Andrews W, Hauth J, Cutter G, HamrickW, Baldus K, Waites K. Isolation of microorganisms from the chorioamnion is twice that from amniotic fluid at caesarean delivery in women with intact membranes. Am J. Obstet. Gynecol. 1993;168:424.
21. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J. Obstet. Gynecol. 1994;171:1660-1667.
22. Dudley DJ. Pre-term labor: An intra-uterine inflammatory response syndrome? J Reprod Immunol 1997;30:93-109. (Pubitemid 27511461)
23. Arntzen KJ, Kjollesdal AM, Halgunset J, Vatten L, Austgulen R. TNF, IL-1, IL-6, IL-8, and soluble TNF receptors in relation to chorioamnionitis and Preterm labor. J Perinat Med 1998;26: 17-26. (Pubitemid 28154324)
24. Steinborn A, Kuhnert M, Halberstadt E. Immunomodulating cytokines induce term and preterm parturition. J Perinat Med 1996;24:381-390. (Pubitemid 26278826)
25. Maeda K, Matsuzaki N, Fuke S, Mitsuda N, Shimoya K, Nakayama M, Suehara N, Aono T. Value of the maternal interleukin 6 level for determination of histologic chorioamnionitis in preterm delivery. Gynecol Obstet Invest 1997;43: 225-231. (Pubitemid 27249949)
26. Saito S, Kasahara T, Kato Y, Ishihara, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993;5: 81-88. (Pubitemid 23098838)
27. Stallmach T, Hebisch G, Joller H, Kolditz P, Engelmann M. Expression pattern of cytokines in the different compartment of the feto-maternal unit under various conditions. Reprod Fertil Dev 1995;7:1573-1580. (Pubitemid 26133270)
28. Romero R, Mazor M, Sepulveda W, Avila C, Copel D, Williams J. Tumour necrosis factor in preterm and term labor. Am J. Obstet. Gynecol. 1992;166:1576-1587.
29. Tanaka Y, Narahara H, Takai J, Yoshimatsu T, Anai T, Miyakawa I. Interleukin-1 (beta) and interleukin-8 in cervicovaginal fluid during pregnancy. Am J. Obstet. Gynecol. 1998;179:644-649. (Pubitemid 28447240)
30. Hiroshige M, Kyoko K, Yasumasa S, Atsushi I, Teruhiko T. Preterm labor and bacterial intraamniotic infection: Arachidonic acid liberation by phospholipase A2 of Fusobacterium nucleatum. Am J. Obstet. Gynecol. 1998;179:1579-1582.
31. Lamont RF, Anthony F, Myatt L, Booth L, Furr PM, Taylor- Robinson D. Production of prostaglandin E2 by human amnion in vitro in response to addition of media conditioned by microorganisms associated with chorioamnionitis and preterm labour. Am J. Obstet. Gynecol. 1990;162:819-825. (Pubitemid 20116350)
32. Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, Mazaki - Tovi S, Than NG, Hassan S, Tromp G. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG 2006;113:118-135. (Pubitemid 44934682)
33. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, Syn HC. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J. Obstet. Gynecol. 1996;174: 1433-1440. (Pubitemid 26165257)
34. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumour necrosis factor-alpha, interleukin-1 beta, and interlekin-8 and the risk for the development of bronchopulmonary dysplasia. Am J. Obstet. Gynecol. 1997;177:825-830. (Pubitemid 27516049)
35. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR. Fetal exposure to an intraamniotic inflammatory and the development of cerebral palsy at the age of three years. Am J. Obstet. Gynecol. 2000;182:675-681. (Pubitemid 30207333)
36. Macones GA, Parry S, Elkousy M, Clothier B, Ural SH, Strauss A. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-enviroment interaction in the etiology of spontaneous preterm birth. Am J. Obstet. Gynecol. 2004;190:1504-1508. (Pubitemid 39006182)
37. Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF. Risk of spontaneous preterm birth is associated with common pro- inflammatory cytokine polymorphisms. Epidemiology 2005;16:469-477. (Pubitemid 40847830)
38. Takashiba S, Narushi K. Gene polymorphisms in periodontal health and disease. Periodontol 2000. 2006;40:94-106. (Pubitemid 43434243)
39. Moore S, Ide M, Randhawa M, Walker JJ, Reid JG, Simpson NA. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease. BJOG 2004;11:1125-1132.
40. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N Engl J Med 1995;333: 1737-1742.
41. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. Br Med J 1994;308:295-298.
42. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-1903. (Pubitemid 16033391)
43. Hill GB. Preterm birth: Associations with genital and possibly oral microflora. Ann Periodontol 1998;3:222-232.
44. Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-177.
45. Moore S, Ide M, Coward PY, Randhawa M, Borkowska E, Baylis R, Wilson RF. A prospective study to investigate the relationship between periodontal disease and adverse pregnancy outcome. Br Dent J 2004;197:251-258. (Pubitemid 39278178)
46. Offenbacher S, Lieff S, Boggess KA, Murtha AP, Madianos PN, Champagne CM, McKaig RG, Jared HL, Mauriello SM, Auten RL Jr, et al. Maternal periodontitis and prematurity, Part 1, Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001;6:164-174.
47. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, McKaig R, Beck J. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67: 1103-1113. (Pubitemid 126613091)
48. Dasanayake AP. Poor periodontal health of the pregnant woman as a risk factor for low birth weight. Ann Periodontol 1998;3: 206-212.
49. Goepfert AR, Jeffcoat MK, Andrews WW, Faye- Petersen O, Cliver SP, Goldenberg RL, Hauth JC. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol 2004;4:777-783. (Pubitemid 40458808)
50. Jeffcoat MK, Geurs NC, Reddy MS, Cliver SP, Goldenberg RL, Hauth JC. Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc 2001;132: 875-880.
51. Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S. Periodontal disease and adverse pregnancy outcomes: A systematic review. BJOG 2006;113:135-142.
52. Rajapakse PS, Nagarathne M, Chandrasekra KB, Dasanayake AP. Periodontal disease and prematurity among non-smokoing Sri Lankan women. J Dent Res 2005;84:274-277. (Pubitemid 43822037)
53. Offenbacher S, Boggess KA, Murtha AP, Jared HL, Lieff S, McKaig RG, Mauriello SM, Moss KL, Beck JD. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol 2006;107:29-36.
54. Srinivas SK, Samuel MD, Stamilio DM, Clothier B, Jeffcoat MK, Parry S, Macones GA, Elovitz MA, Metlay J. Periodontal disease and adverse pregnancy outcomes: is there an association? Am J. Obstet. Gynecol. 2009;200:497.e1-497. e8.
55. Boggess KA, Moss K, Madianos P, Murtha AP, Beck J, Offenbacher S. Fetal immune response to oral pathogens and risk of preterm birth.AmJ Obstet Gynecol 2005;193:1121-1126. (Pubitemid 41285505)
56. Offenbacher S, Jared HL, O' Reilly PG, Wells SR, Salvi GE, Lawrence HP, Socransky SS, Beck JD. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 1998;3:233-250.
57. Rosenstein IJ, Morgan DJ, Lamont RF, Sheehan M, Dore CJ, Hay PE, Taylor-Robinson D. Effect of intravaginal clindamycin cream on pregnancy outcome and on abnormal vaginal microbial flora of pregnant women. Infect Dis Obstet Gynecol 2000;8:158-165. (Pubitemid 30612893)
58. Duff P, Lee ML, Hillier SL, Herd LM, Krohn MA, Eschenbach DA. Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet.Gynecol. 1991;77:431-435.
59. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study. Am J. Obstet. Gynecol. 1994;171:345-347.
60. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-1736. (Pubitemid 26007124)
61. Joesoef MR, Hillier SL, Wiknjosastro G, Sumampouw H, Linnan M, Norojono W, Idajadi A, Utomo B. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J. Obstet. Gynecol. 1995;173:1527-1531.
62. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorgard K, McFee J. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J. Obstet. Gynecol. 1995;173:157-167.
63. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, McDonald PJ. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): A randomised, placebo controlled trial. Br J Obstet. Gynaecol. 1997;104:1391-1397. (Pubitemid 27517637)
64. Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: A randomised placebo-controlled double-blind trial. Br J Obstet. Gynaecol. 1999;106:652-657. (Pubitemid 29304386)
65. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000;342: 534-540. (Pubitemid 30117893)
66. Kurkinen-Raty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, Jouppil P. A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 2000;107:1427-1432.
67. Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: A randomized, controlled trial. Obstet Gynecol 2001;97:643-648.
68. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, Ernest JM, Heine RP, Wapner RJ, Trout W, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-493. (Pubitemid 32758500)
69. Porter K, Rambo D, Jazayeri M, and Prien S. Prospective randomized trial of once versus twice a day metronidazole vaginal in obstetrical identified with bacterial vaginosis. Am J. Obstet. Gynecol. 2001;184:S166.
70. Odendaal HJ, Popov I, Schoeman J, Smith M, Grove D. Preterm labour - is bacterial vaginosis involved? S Afr Med J 2002;92:231-234. (Pubitemid 34567767)
71. Guaschino S, Ricci E, Franchi M, Frate GD, Tibaldi C, Santo DD, Ghezzi F, Benedetto C, Seta FD, Parazzini F. Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: A randomised trial. Eur J Obstet Gynecol Reprod Biol 2003;110:149-152. (Pubitemid 37101310)
72. Lamont RF, Duncan SL, Mandal D, Bassett P. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003;101: 516-522. (Pubitemid 36288492)
73. Ugwumadu A, Manyonda I, Reid F, Hay P. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: A randomised controlled trial. Lancet 2003;361: 983-988. (Pubitemid 36351366)
74. Kiss H, Petricevic L, Husslein P. Prospective randomized controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004;329:371.
75. Larsson PG, Fahraeus L, Carlsson B, Jakobsson T, Forsum U. Late miscarriage and preterm birth after treatment with clindamycin: A randomised consent design study according to Zelen. BJOG 2006;113:629-637. (Pubitemid 43781693)
76. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007;1:CD000262.
77. Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 2008;2:CD006178.
78. Hutzal CE, Boyle EM, Kenyon SL, Nash JV, Winsor S, Taylor DJ, Kirpalani H. Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: A metaanalysis. Am J. Obstet. Gynecol. 2008;199:620-628.
79. Simcox R, Sin WT, Seed PT, Briley A, Shennan AH. Prophylactic antibiotics for the prevention of preterm birth in women at risk: A meta-analysis. Aust N Z J Obstet. Gynaecol. 2007;47:368-377. (Pubitemid 47433839)
80. Lamont RF. Antibiotics used in women at risk of preterm birth. Am J. Obstet. Gynecol. 2008;199:583-584.
81. Hay PE, Taylor-Robinson D, Lamont RF. Preterm premature rupture of membranes. Lancet 1996;347:203.
82. Lamont RF. Infection and preterm labour. Br J Obstet. Gynaecol. 1998;105:1339-1340.
83. Lamont RF. Antibiotics for the prevention of preterm birth. N Engl J Med 2000;342:581-583. (Pubitemid 30117901)
84. Lamont RF, Taylor-Robinson D, Hay PE. Antibiotics for adverse outcomes of pregnancy. Lancet 2001;358:1728-1729.
85. Lamont RF. Association between cerebral palsy and erythromycin. Lancet 2009;373:26.
86. Mason MR, Adrinkra PE, Lamont RF. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased risk: A randomised placebo-controlled double-blind trial. BJOG 2000; 107:295-296. (Pubitemid 30081602)
87. Lamont DF. Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth. BJOG 2003; 110:788-789.
88. Lamont RF. The maternal fetal medicine network trial. Am J. Obstet. Gynecol. 2005;193:306-307.
89. Workoski KA, Berman SM. Sexually transmitted disease treatment guidelines. MMWR Recomm Rep 2006;55:1-94.
90. Barry AL, Thornsberry C, Jones RN. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. Antimicrob.Agents Chemother 1987;31:343-345. (Pubitemid 17011269)
91. Young RA, Gonzalez JP, Sorkin EM. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1989;37:8-41. (Pubitemid 19086730)
92. Hillier SL, Holmes KK. Bacterial Vaginosis. In: Holmes KK, Markowitz LE, Spellacy W, Wiggins R, editors. Sexually transmitted diseases. New York: McGraw-Hill; 1990. Pp 547-550.
93. Spiegel CA, Eschenbach DA, Amsel R, Holmes KK. Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy. J Infect Dis 1983;148: 817-822. (Pubitemid 14244267)
94. Spiegel CA. Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds. Antimicrob.Agents Chemother. 1987;31:249-252. (Pubitemid 17011246)
95. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J.Invest Dermatol. 1978;70:51-55. (Pubitemid 8262275)
96. Hand WL, Hand DL, King-Thompson NL. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1990;34:863-870. (Pubitemid 20142414)
97. Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi M. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: Analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 1994;105:308-316. (Pubitemid 24318005)
98. Mikasa K, Kita E, Sawaki M, Kunimatsu M, Hamada K, Konishi M, Kashiba S, Narita N. The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice. J Antimicrob Chemother 1992;30:339-348.
99. Takeshita K, Yamagishi I, Harada M, Otomo S, Nakagawa T, Mizushima Y. Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp Clin Res 1989;15:527-533. (Pubitemid 20106197)
100. Lamont RF, Jones BM, Mandal D, Hay PE, Sheehan M. The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect Dis Obstet Gynecol 2003;11:181-189. (Pubitemid 38101437)
101. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, McDonald PJ. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: A randomized controlled trial. Obstet Gynecol. 1994;84:343-348. (Pubitemid 24267289)
102. Ugwumadu A, Reid F, Hay P, Manyonda I. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol. 2004;104:114-119. (Pubitemid 40458913)
103. Vermeulen GM, van Zwet AA, Bruinse HW. Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous preterm birth. BJOG 2001;108:697-700. (Pubitemid 32778274)
104. Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis. Antimicrob Agents Chemother 2002;46:3995-3996. (Pubitemid 35403282)
105. Xiao JC, Xie LF, Fang SL, Gao MY, Zhu Y, Song LY, Zhong HM, Lun ZR. Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro. Parasitol Res 2006;100:123-130. (Pubitemid 44786639)
106. Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL, Jr., Martin DH. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 2004;4:5.
107. De Backer E, Dubreuil L, Brauman M, Acar J, Vaneechoutte M. In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. Clin.Microbiol. Infect. 2010;16:470-472.
108. Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den BT, Riphagen I, Van Lierde S. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009;116:1315-1324.
109. Workowski KA, Berman SM. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007;44:S73-S76. (Pubitemid 46452040)
110. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Hovarth LB, Kuzevska I, Fairley CK. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-1486. (Pubitemid 43794575)
111. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl JMed 2005;353:1899-1911. (Pubitemid 41565955)
112. Thies FL, Konig W, Konig B. Rapid characterization of the normal and disturbed vaginal microbiota by application of 16S rRNA gene terminal RFLP fingerprinting. J Med Microbiol2007;56:755-761. (Pubitemid 46911229)
113. Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G, Donders GG, Brigidi P. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed byPCR-denaturing gradient gel electrophoresis and real-time PCR. Appl EnvironMicrobiol 2007;73:5731-5741. (Pubitemid 47462983)
114. Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004;150:2565-2573. (Pubitemid 39173262)
115. Oakley BB, Fiedler TL, Marrazzo JM, Fredricks DN. Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol 2008;74:4898-4909.
116. Wertz J, Isaacs-Cosgrove N, Holzman C, Marsh TL. Temporal shifts in microbial communities in nonpregnant African-American women with and without bacterial vaginosis. Interdiscip Perspect Infect Dis 2008;2008:181-253.
117. Biagi E, Vitali B, Pugliese C, CandelaM, Donders GG, Brigidi P. Quantitative variations in the vaginal bacterial population associated with asymptomatic infections:a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis 2009;28: 281-285.
118. Haggerty CL, Totten PA, Ferris M, Martin DH, Hoferka S, Astete SG, Ondondo R, Norori J, Ness RB. Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect 2009; 85:242-248.
119. Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P, Nelson K. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093-1097.
120. Cu-Uvin S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIVseronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis 1999;29:1145-1150. (Pubitemid 30265631)
121. Larsson PG, Platz-Christensen JJ, Dalaker K, Eriksson K, Fahraeus L, Irminger K, Jerve F, Stray-Pedersen B, Wolner- Hanssen P. Treatment with 2% clindamycin vaginal cream prior to first trimester surgical abortion to reduce signs of postoperative infection: A prospective, double-blinded, placebo-controlled, multicenter study. Acta. Obstet. Gynecol. Scand 2000;79:390-396. (Pubitemid 30261147)
122. Llahi-Camp JM, Rai R, Ison C, Regan L, Taylor-Robinson D. Association of bacterial vaginosis with a history of second trimester miscarriage. Human Reprod 1996;11:1575-1578. (Pubitemid 26335116)
123. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya - Achola JO, Bwayo J, Kreiss J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863-1868.
124. Oleen-Burkey MA, Hillier SL. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 1995;3:149-157.
125. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 2005;32: 446-453. (Pubitemid 40875382)
126. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ 1999;319:220-223. (Pubitemid 29338689)
127. Schwebke JR. Gynecologic consequences of bacterial vaginosis. Obstet Gynecol Clin North Am 2003;30:685-694. (Pubitemid 38018632)
128. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-550. (Pubitemid 27348430)
129. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 1998;12:1699-1706. (Pubitemid 28418342)
130. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet.Gynecol. 1990;75:52-58. (Pubitemid 20047932)
131. Wilson JD, Ralph SG, Rutherford AJ. Rates of bacterial vaginosis in women undergoing in vitro fertilisation for different types of infertility. BJOG 2002;109:714-717. (Pubitemid 37329286)
132. Goplerud CP, Ohm MJ, Galask RP. Aerobic and anaerobic flora of the cervix during pregnancy and the puerperium. Am.J.Obstet. Gynecol. 1976;126:858-868. (Pubitemid 8001366)
133. Lamont RF, Taylor-Robinson D, Hay PE. Antibiotics for adverse outcomes of pregnancy. Lancet 2001;358:1728-1729.
134. Lamont RF. Association between cerebral palsy and erythromycin. Lancet 2009;373:26.
135. Mason MR, Adrinkra PE, Lamont RF. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased risk: A randomised placebo-controlled double-blind trial. BJOG 2000;107:295-296. (Pubitemid 30081602)
136. Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal and neonatal infection. Obstet Gynecol 1992;79:75-80.
137. Shim SS, Romero R, Hong JS, Park CW, Jun JK, Kim BI, Yoon BH. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J. Obstet. Gynecol. 2004;191:1339-1345. (Pubitemid 39421594)
138. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295-298.
139. Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-177.
140. Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: Association in early and late pregnancy. Am J. Obstet. Gynecol. 1993;169:175-178. (Pubitemid 23223954)
141. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, Parker R. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J. Obstet. Gynecol. 1994;170:1048-1059.
142. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG II, Rao AV, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333: 1737-1742.
143. Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, Johnson F, Iams JD, Thom E, Andrews WW. The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J. Obstet. Gynecol. 1995;173:1231-1235.
144. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-1903. (Pubitemid 16033391)
145. Wennerholm UB, Holm B, Mattsby-Baltzer I, Nielsen T, Platz- Christensen J, Sundell G, Hosseini N, Hagberg H. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet. Gynaecol. 1997;104:1398-1404. (Pubitemid 27517638)
146. Gratacos E, Figueras F, Barranco M, Vila J, Cararach V, Alonso PL, Fortuny A. Spontaneous recovery of bacterial vaginosis during pregnancy is not associated with an improved perinatal outcome. Acta. Obstet. Gynecol. Scand 1998;77:37-40. (Pubitemid 28062360)
147. Holst E, Goffeng AR, Andersch B. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J Clin Microbiol 1994;32:176-186. (Pubitemid 24016804)
148. Eschenbach DA, Gravett MG, Chen KC, Hoyme UB, Holmes KK. Bacterial vaginosis during pregnancy. An association with prematurity and postpartum complications. Scand J Urol Nephrol Suppl 1984;86:213-222.
149. McDonald HM, O'Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ. Prenatal microbiological risk factors associated with preterm birth. Br J Obstet. Gynaecol. 1992;99:190-196.
150. Lamont RF. Bacterial vaginosis. In: Critchley H, Bennett P, Thornton S, editors. Preterm birth. London: RCOG Press; 2004. pp. 163-180.
151. Berg TG, Philpot KL, Welsh MS, Sanger WG, Smith CV. Ureaplasma/ Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. J Perinatol 1999;19:275-277.
152. Cassell GH, Davis RO, Waites KB, Brown MB, Marriott PA, Stagno S, Davis JK. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10:294-302. (Pubitemid 14193583)
153. Gerber S, Vial Y, Hohlfeld P, Witkin SS. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003;187:518-521. (Pubitemid 36184596)
154. Gray DJ, Robinson HB, Malone J, Thomson RB, Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992;12:111-117.
155. Horowitz S, Mazor M, Romero R, Horowitz J, Glezerman M. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995;40:375-379.
156. Nguyen DP, Gerber S, Hohlfeld P, Sandrine G, Witkin SS. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004;32:323-326. (Pubitemid 39013846)
157. Perni SC, Vardhana S, Korneeva I, Tuttle SL, Paraskevas LR, Chasen ST, Kalish RB, Witkin SS. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: Association with amniotic fluid cytokine levels and pregnancy outcome. Am J. Obstet. Gynecol. 2004;191:1382-1386. (Pubitemid 39421600)
158. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: The ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 2001;357:989-994. (Pubitemid 32285390)
159. Kenyon S, Pike K, Jones DR, Brocklehurst P,Marlow N, Salt A, Taylor DJ. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008;372:1319-1327.
160. Bakketeig LS, Hoffman HJ, Harley EE. The tendency to repeat gestational age and birth weight in successive births. Am J. Obstet. Gynecol. 1979;135:1086-1103. (Pubitemid 10181939)
161. Hoffman HJ, Bakketeig LS. Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol 1984;27: 539-552. (Pubitemid 14043380)
162. Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: The PREMET Study. BJOG 2006;113:65-74.
163. Lamont RF, Dragovic B. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: The PREMET Study by Shennan et al. BJOG 2006;113:850-851. (Pubitemid 43961755)
164. Morgan DJ, Taylor-Robinson D. Late miscarriage and preterm birth after treatment with clindamycin: A randomised consent design study according to Zelen. BJOG 2006;113:1483. (Pubitemid 44736701)
165. Mombelli A, Samaranayake LP. Topical and systemic antibiotics in the management of periodontal diseases. Int Dent J 2004;54:3-14. (Pubitemid 38249662)
166. Jeffcoat MK, Hauth JC, Geurs NC, Reddy MS, Cliver SP, Hodgkins PM, Goldenberg RL. Periodontal disease and preterm birth: results of a pilot intervention study. J Periodontol 2003;74:1214-1218. (Pubitemid 37161742)
167. Sedlacek MJ, Walker C. Antibiotic resistance in an in vitro subgingivial biofilm model. Oral Microbiol Immunol 2007;22: 333-339. (Pubitemid 47347820)
168. Lopez NJ, Smith PC, Gutierrez J. Periodontal therapy may reduce the risk of preterm low birth weight in women with periodontal disease: A randomised controlled trial. J Periodontol 2002;73:911-924. (Pubitemid 34965825)
169. Lopez NJ, Da Silva I, Ipinza J, Gutierrez J. Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy associated gingivitis. J Periodontol 2005;76: 2144-2153. (Pubitemid 41748964)
170. Polyzos NP, Polyzos IP, Mauri D, Tzioras S, Tsappi M, Cortinovis I, Casazza G. Effect of periodontal disease treatment during pregnancy on preterm birth incidence: A metaanalysis of randomised trials. Am J. Obstet. Gynecol. 2009;200:225-232.